Trade GlaxoSmithKline PLC - GSKl CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.050 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.025295% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.003377% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | GBP | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United Kingdom of Great Britain and Northern Ireland | ||||||||
| Commission on trade | 0% |
| Prev. Close | 15.265 |
| Open | 15.205 |
| 1-Year Change | 9.31% |
| Day's Range | 15.205 - 15.525 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 15.250 | 0.105 | 0.69% | 15.145 | 15.305 | 14.880 |
| Jul 24, 2024 | 15.040 | 0.105 | 0.70% | 14.935 | 15.080 | 14.845 |
| Jul 23, 2024 | 14.990 | -0.175 | -1.15% | 15.165 | 15.370 | 14.990 |
| Jul 22, 2024 | 15.250 | -0.015 | -0.10% | 15.265 | 15.305 | 15.190 |
| Jul 19, 2024 | 15.175 | 0.145 | 0.96% | 15.030 | 15.235 | 15.015 |
| Jul 18, 2024 | 15.290 | -0.100 | -0.65% | 15.390 | 15.455 | 15.225 |
| Jul 17, 2024 | 15.295 | 0.360 | 2.41% | 14.935 | 15.305 | 14.895 |
| Jul 16, 2024 | 14.985 | 0.325 | 2.22% | 14.660 | 15.000 | 14.660 |
| Jul 15, 2024 | 14.860 | -0.120 | -0.80% | 14.980 | 15.160 | 14.860 |
| Jul 12, 2024 | 15.180 | -0.010 | -0.07% | 15.190 | 15.275 | 15.110 |
| Jul 11, 2024 | 14.985 | 0.075 | 0.50% | 14.910 | 15.125 | 14.910 |
| Jul 10, 2024 | 15.020 | -0.010 | -0.07% | 15.030 | 15.130 | 14.965 |
| Jul 9, 2024 | 15.090 | -0.020 | -0.13% | 15.110 | 15.220 | 15.070 |
| Jul 8, 2024 | 15.040 | 0.100 | 0.67% | 14.940 | 15.160 | 14.845 |
| Jul 5, 2024 | 15.045 | -0.055 | -0.36% | 15.100 | 15.250 | 14.780 |
| Jul 4, 2024 | 15.085 | -0.040 | -0.26% | 15.125 | 15.160 | 15.050 |
| Jul 3, 2024 | 14.950 | -0.105 | -0.70% | 15.055 | 15.055 | 14.945 |
| Jul 2, 2024 | 15.000 | -0.085 | -0.56% | 15.085 | 15.145 | 14.925 |
| Jul 1, 2024 | 15.255 | 0.120 | 0.79% | 15.135 | 15.355 | 15.045 |
| Jun 28, 2024 | 15.145 | -0.200 | -1.30% | 15.345 | 15.385 | 15.145 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
GSK Company profile
GlaxoSmithKline PLC - GSK CFD
GlaxoSmithKline (GSK) is a global healthcare company focussed in pharmaceuticals, vaccine development and consumer healthcare products.
The company began as an apothecary shop in London in 1715. Today, GlaxoSmithKline is headquartered in Brentford, England, with regional offices in the US and Singapore. GlaxoSmithKline’s primary listing is on the London Stock Exchange under the ticker symbol ‘GSK’. The GSK stock price in the form of American depositary shares is listed on the New York Stock Exchange.
GlaxoSmithKline’s pharmaceutical business covers a broad portfolio of medicines in respiratory, HIV, immuno-inflammation and oncology. The company has a leadership position in respiratory disease medicines. GlaxoSmithKline’s HIV business is managed through its unit ViiV Healthcare, with Pfizer and Shionogi as minority shareholders.
In addition to respiratory and HIV treatments, the company has a portfolio of pharmaceutical products for the treatment of conditions such as lupus, urology and anti-infectives.
Its Established Products Portfolio (EPP) includes mature medicines in the areas of anti-infectives, allergy, central nervous system, dermatology, respiratory and urology. These products are an important part of our Emerging Markets business.
GlaxoSmithKline is actively researching the World Health Organisation’s three priority diseases - HIV/AIDS, tuberculosis and malaria.
GlaxoSmithKline is also one of the world’s largest vaccine companies with a portfolio of more than 20 vaccines. The company has 12 vaccine manufacturing sites around the world. One of its four global R&D centres is dedicated to mRNA technology.
GlaxoSmithKline’s consumer healthcare business has portfolio of brands that include Sensodyne, Parodontax, Polident, Advil, Voltaire, Panadol, Striven, Theraflu and Centrum across oral health, pain relief, cold, flu and allergy, digestive health, and vitamins, mineral and supplements segments. GlaxoSmithKline is set to spin-off its consumer healthcare business into an independent company under the name ‘Haleon’.’
The company pays dividends on a quarterly basis, in July, October, January and April.
Follow the GlaxoSmithKline stock price live at Capital.com today.
| Industry: | Pharmaceuticals (NEC) |
980 Great West Road
BRENTFORD
MIDDLESEX TW8 9GS
GB
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com